<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33260927</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>27</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>How Degeneration of Cells Surrounding Motoneurons Contributes to Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2550</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9122550</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder characterized by the progressive degeneration of upper and lower motoneurons. Despite motoneuron death being recognized as the cardinal event of the disease, the loss of glial cells and interneurons in the brain and spinal cord accompanies and even precedes motoneuron elimination. In this review, we provide striking evidence that the degeneration of astrocytes and oligodendrocytes, in addition to inhibitory and modulatory interneurons, disrupt the functionally coherent environment of motoneurons. We discuss the extent to which the degeneration of glial cells and interneurons also contributes to the decline of the motor system. This pathogenic cellular network therefore represents a novel strategic field of therapeutic investigation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crab&#xe9;</LastName><ForeName>Roxane</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, UMR1051, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aimond</LastName><ForeName>Franck</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, UMR1051, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gosset</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9104-8688</Identifier><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, UMR1051, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scamps</LastName><ForeName>Fr&#xe9;d&#xe9;rique</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, UMR1051, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raoul</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0561-6851</Identifier><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, UMR1051, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Kazan Federal University, 420008 Kazan, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007395" MajorTopicYN="N">Interneurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009836" MajorTopicYN="N">Oligodendroglia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">cortex</Keyword><Keyword MajorTopicYN="N">degeneration</Keyword><Keyword MajorTopicYN="N">interneuron</Keyword><Keyword MajorTopicYN="N">motoneuron</Keyword><Keyword MajorTopicYN="N">oligodendrocytes</Keyword><Keyword MajorTopicYN="N">spinal cord</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33260927</ArticleId><ArticleId IdType="pmc">PMC7760029</ArticleId><ArticleId IdType="doi">10.3390/cells9122550</ArticleId><ArticleId IdType="pii">cells9122550</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Aebischer J., Bernard-Marissal N., Pettmann B., Raoul C. Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis. J. Neurodegener. Dis. 2013;2013:746845. doi: 10.1155/2013/746845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/746845</ArticleId><ArticleId IdType="pmc">PMC4437334</ArticleId><ArticleId IdType="pubmed">26316997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruegsegger C., Saxena S. Proteostasis impairment in ALS. Brain Res. 2016;1648:571&#x2013;579. doi: 10.1016/j.brainres.2016.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.03.032</ArticleId><ArticleId IdType="pubmed">27033833</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunes Z.I., Kan V.W.Y., Ye X., Liebscher S. Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology. Front. Neurosci. 2020;14:573. doi: 10.3389/fnins.2020.00573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00573</ArticleId><ArticleId IdType="pmc">PMC7311855</ArticleId><ArticleId IdType="pubmed">32625051</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowerman M., Vincent T., Scamps F., Perrin F.E., Camu W., Raoul C. Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis. Front. Cell Neurosci. 2013;7:214. doi: 10.3389/fncel.2013.00214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00214</ArticleId><ArticleId IdType="pmc">PMC3833095</ArticleId><ArticleId IdType="pubmed">24312006</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 2018;126:31&#x2013;38. doi: 10.1016/j.neures.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Bento-Abreu A., Nonneman A., Haeck W., Staats K., Geelen V., Hersmus N., Kusters B., Van Den Bosch L., Van Damme P., et al. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain. 2013;136:471&#x2013;482. doi: 10.1093/brain/aws339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws339</ArticleId><ArticleId IdType="pmc">PMC3572934</ArticleId><ArticleId IdType="pubmed">23378219</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A., Lobsiger C.S., Boillee S. New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2019;32:764&#x2013;770. doi: 10.1097/WCO.0000000000000729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000729</ArticleId><ArticleId IdType="pubmed">31306211</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer D., Cordera S., Cavalla P., Migheli A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 1996;139:27&#x2013;33. doi: 10.1016/0022-510X(96)00073-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(96)00073-1</ArticleId><ArticleId IdType="pubmed">8899654</ArticleId></ArticleIdList></Reference><Reference><Citation>Murayama S., Inoue K., Kawakami H., Bouldin T.W., Suzuki K. A unique pattern of astrocytosis in the primary motor area in amyotrophic lateral sclerosis. Acta Neuropathol. 1991;82:456&#x2013;461. doi: 10.1007/BF00293379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00293379</ArticleId><ArticleId IdType="pubmed">1785258</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A., Myszczynska M.A., Castelli L.M., O&#x2018;Neill B., Kim Y., Talbot J., Nyberg S., Nyamali I., Heath P.R., Stopford M.J., et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;635. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A., McAvoy K., Krishnamurthy K., Trotti D., Pasinelli P. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia. 2018;66:1016&#x2013;1033. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Aebischer J., Cassina P., Otsmane B., Moumen A., Seilhean D., Meininger V., Barbeito L., Pettmann B., Raoul C. IFNgamma triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1. Cell Death Differ. 2011;18:754&#x2013;768. doi: 10.1038/cdd.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2010.143</ArticleId><ArticleId IdType="pmc">PMC3131923</ArticleId><ArticleId IdType="pubmed">21072055</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M., Cassina P., Vargas M.R., Castellanos R., Viera L., Beckman J.S., Estevez A.G., Barbeito L. Astrocytic production of nerve growth factor in motor neuron apoptosis: Implications for amyotrophic lateral sclerosis. J. Neurochem. 2004;89:464&#x2013;473. doi: 10.1111/j.1471-4159.2004.02357.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02357.x</ArticleId><ArticleId IdType="pubmed">15056289</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto M.C., Muotri A.R., Mu Y., Smith A.M., Cezar G.G., Gage F.H. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell. 2008;3:649&#x2013;657. doi: 10.1016/j.stem.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.10.001</ArticleId><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A., Ben-Dor I., Ottolenghi M., Turetsky T., Gil Y., Sweetat S., Perez L., Belzer V., Casden N., Steiner D., et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;289. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Houseweart M.K., Brown R.H., Jr., Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2000;97:13901&#x2013;13906. doi: 10.1073/pnas.240305897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.240305897</ArticleId><ArticleId IdType="pmc">PMC17673</ArticleId><ArticleId IdType="pubmed">11095709</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D., Brambilla L., Valori C.F., Roncoroni C., Crugnola A., Yokota T., Bredesen D.E., Volterra A. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 2008;15:1691&#x2013;1700. doi: 10.1038/cdd.2008.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.99</ArticleId><ArticleId IdType="pubmed">18617894</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Martinez-Palma L., Cassina P., Beckman J., Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Palma L., Miquel E., Lagos-Rodriguez V., Barbeito L., Cassina A., Cassina P. Mitochondrial Modulation by Dichloroacetate Reduces Toxicity of Aberrant Glial Cells and Gliosis in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2019;16:203&#x2013;215. doi: 10.1007/s13311-018-0659-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-018-0659-7</ArticleId><ArticleId IdType="pmc">PMC6361051</ArticleId><ArticleId IdType="pubmed">30159850</ArticleId></ArticleIdList></Reference><Reference><Citation>Komine O., Yamashita H., Fujimori-Tonou N., Koike M., Jin S., Moriwaki Y., Endo F., Watanabe S., Uematsu S., Akira S., et al. Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes. Cell Death Differ. 2018;25:2130&#x2013;2146. doi: 10.1038/s41418-018-0098-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0098-3</ArticleId><ArticleId IdType="pmc">PMC6261996</ArticleId><ArticleId IdType="pubmed">29568058</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Diaz-Amarilla P., Olivera-Bravo S., Isasi E., Drechsel D.A., Lopez N., Bradford C.S., Ireton K.E., Beckman J.S., Barbeito L. Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS. Front. Cell Neurosci. 2013;7:274. doi: 10.3389/fncel.2013.00274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00274</ArticleId><ArticleId IdType="pmc">PMC3871969</ArticleId><ArticleId IdType="pubmed">24399933</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Barbeito L., Yamanaka K. Phenotypic heterogeneity of astrocytes in motor neuron disease. Clin. Exp. Neuroimmunol. 2018;9:225&#x2013;234. doi: 10.1111/cen3.12476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen3.12476</ArticleId><ArticleId IdType="pmc">PMC6282976</ArticleId><ArticleId IdType="pubmed">30555538</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotshenker S. The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease. J. Mol. Neurosci. 2009;39:99&#x2013;103. doi: 10.1007/s12031-009-9186-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-009-9186-7</ArticleId><ArticleId IdType="pubmed">19253007</ArticleId></ArticleIdList></Reference><Reference><Citation>Huysentruyt L.C., Akgoc Z., Seyfried T.N. Hypothesis: Are neoplastic macrophages/microglia present in glioblastoma multiforme? ASN Neuro. 2011;3 doi: 10.1042/AN20110011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/AN20110011</ArticleId><ArticleId IdType="pmc">PMC3178415</ArticleId><ArticleId IdType="pubmed">21834792</ArticleId></ArticleIdList></Reference><Reference><Citation>Morizawa Y.M., Hirayama Y., Ohno N., Shibata S., Shigetomi E., Sui Y., Nabekura J., Sato K., Okajima F., Takebayashi H., et al. Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway. Nat. Commun. 2017;8:28. doi: 10.1038/s41467-017-00037-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00037-1</ArticleId><ArticleId IdType="pmc">PMC5481424</ArticleId><ArticleId IdType="pubmed">28642575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Riani M., Diaz-Amarilla P., Isasi E., Casanova G., Barbeito L., Olivera-Bravo S. Ultrastructural features of aberrant glial cells isolated from the spinal cord of paralytic rats expressing the amyotrophic lateral sclerosis-linked SOD1G93A mutation. Cell Tissue Res. 2017;370:391&#x2013;401. doi: 10.1007/s00441-017-2681-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-017-2681-1</ArticleId><ArticleId IdType="pubmed">28864831</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J., Wu Y.L., Chen B.J., Zhang W., Tanaka Y., Sugiyama H. The C-kit receptor-mediated signal transduction and tumor-related diseases. Int. J. Biol. Sci. 2013;9:435&#x2013;443. doi: 10.7150/ijbs.6087.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.6087</ArticleId><ArticleId IdType="pmc">PMC3654492</ArticleId><ArticleId IdType="pubmed">23678293</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Ibarburu S., Barreto-Nunez R., Babdor J., Maciel T.T., Guillo M., Gros L., Dubreuil P., Diaz-Amarilla P., Cassina P., et al. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J. Neuroinflammation. 2016;13:177. doi: 10.1186/s12974-016-0620-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0620-9</ArticleId><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel E., Cassina A., Martinez-Palma L., Bolatto C., Trias E., Gandelman M., Radi R., Barbeito L., Cassina P. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e34776. doi: 10.1371/journal.pone.0034776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034776</ArticleId><ArticleId IdType="pmc">PMC3318006</ArticleId><ArticleId IdType="pubmed">22509356</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana F., Brambilla L., Valori C.F., Bergamaschi C., Roncoroni C., Aronica E., Volterra A., Bezzi P., Rossi D. The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals. Hum. Mol. Genet. 2012;21:826&#x2013;840. doi: 10.1093/hmg/ddr513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr513</ArticleId><ArticleId IdType="pubmed">22072391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarburu S., Trias E., Lago N., Peluffo H., Barreto-Nunez R., Varela V., Beckman J.S., Barbeito L. Focal Transplantation of Aberrant Glial Cells Carrying the SOD1G93A Mutation into Rat Spinal Cord Induces Extensive Gliosis. Neuroimmunomodulation. 2017;24:143&#x2013;153. doi: 10.1159/000480639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000480639</ArticleId><ArticleId IdType="pubmed">29131016</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Bilican B., Barmada S.J., Ando D.M., Zhao C., Siller R., Burr K., Haghi G., Story D., Nishimura A.L., et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2013;110:4697&#x2013;4702. doi: 10.1073/pnas.1300398110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1300398110</ArticleId><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall C.E., Yao Z., Choi M., Tyzack G.E., Serio A., Luisier R., Harley J., Preza E., Arber C., Crisp S.J., et al. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS. Cell Rep. 2017;19:1739&#x2013;1749. doi: 10.1016/j.celrep.2017.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.024</ArticleId><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A.U., Minhas P.S., Liddelow S.A., Haileselassie B., Andreasson K.I., Dorn G.W., 2nd, Mochly-Rosen D. Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat. Neurosci. 2019;22:1635&#x2013;1648. doi: 10.1038/s41593-019-0486-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0486-0</ArticleId><ArticleId IdType="pmc">PMC6764589</ArticleId><ArticleId IdType="pubmed">31551592</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., Munch A.E., Chung W.S., Peterson T.C., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartline D.K., Colman D.R. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr. Biol. 2007;17:R29&#x2013;R35. doi: 10.1016/j.cub.2006.11.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2006.11.042</ArticleId><ArticleId IdType="pubmed">17208176</ArticleId></ArticleIdList></Reference><Reference><Citation>Funfschilling U., Supplie L.M., Mahad D., Boretius S., Saab A.S., Edgar J., Brinkmann B.G., Kassmann C.M., Tzvetanova I.D., Mobius W., et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012;485:517&#x2013;521. doi: 10.1038/nature11007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11007</ArticleId><ArticleId IdType="pmc">PMC3613737</ArticleId><ArticleId IdType="pubmed">22622581</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Oligodendroglia: Metabolic supporters of neurons. J. Clin. Investig. 2017;127:3271&#x2013;3280. doi: 10.1172/JCI90610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90610</ArticleId><ArticleId IdType="pmc">PMC5669561</ArticleId><ArticleId IdType="pubmed">28862639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.H., Li Y., Fukaya M., Lorenzini I., Cleveland D.W., Ostrow L.W., Rothstein J.D., Bergles D.E. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 2013;16:571&#x2013;579. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Chung A.Y., Na J.E., Lee S.J., Jeong S.H., Kim E., Sun W., Rhyu I.J., Park H.C. Myelin degeneration induced by mutant superoxide dismutase 1 accumulation promotes amyotrophic lateral sclerosis. Glia. 2019;67:1910&#x2013;1921. doi: 10.1002/glia.23669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23669</ArticleId><ArticleId IdType="pubmed">31290185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Morrison B.M., Li Y., Lengacher S., Farah M.H., Hoffman P.N., Liu Y., Tsingalia A., Jin L., Zhang P.W., et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443&#x2013;448. doi: 10.1038/nature11314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11314</ArticleId><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Meyer K., Sherwood T.W., Vick J., Likhite S., Frakes A., Miranda C.J., Braun L., Heath P.R., Pineda R., et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc. Natl. Acad. Sci. USA. 2016;113:E6496&#x2013;E6505. doi: 10.1073/pnas.1607496113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607496113</ArticleId><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Ansorge O., Strong M., Bilbao J., Zinman L., Ang L.C., Baker M., Stewart H., Eisen A., Rademakers R., et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: Two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011;122:87&#x2013;98. doi: 10.1007/s00401-011-0838-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0838-7</ArticleId><ArticleId IdType="pmc">PMC3319073</ArticleId><ArticleId IdType="pubmed">21604077</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M., Scott C., Gamarallage M.P., Lunn D., Carpenter K., McDonough E., Meyer D., Kaanumalle S., Santamaria-Pang A., Turner M.R., et al. Quantitative patterns of motor cortex proteinopathy across ALS genotypes. Acta Neuropathol. Commun. 2020;8:98. doi: 10.1186/s40478-020-00961-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00961-2</ArticleId><ArticleId IdType="pmc">PMC7331195</ArticleId><ArticleId IdType="pubmed">32616036</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohan Z., Matej R., Rusina R., Kovacs G.G. Oligodendroglial response in the spinal cord in TDP-43 proteinopathy with motor neuron involvement. Neurodegener. Dis. 2014;14:117&#x2013;124. doi: 10.1159/000362929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000362929</ArticleId><ArticleId IdType="pubmed">25115814</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F., Morita M., et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008;64:60&#x2013;70. doi: 10.1002/ana.21425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden Broeck L., Callaerts P., Dermaut B. TDP-43-mediated neurodegeneration: Towards a loss-of-function hypothesis? Trends Mol. Med. 2014;20:66&#x2013;71. doi: 10.1016/j.molmed.2013.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2013.11.003</ArticleId><ArticleId IdType="pubmed">24355761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Ho W.Y., Lim K., Feng J., Tucker-Kellogg G., Nave K.A., Ling S.C. Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination. Proc. Natl. Acad. Sci. USA. 2018;115:E10941&#x2013;E10950. doi: 10.1073/pnas.1809821115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1809821115</ArticleId><ArticleId IdType="pmc">PMC6243235</ArticleId><ArticleId IdType="pubmed">30373824</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Oussini H.E., Mersmann S., Drenner K., Wagner M., Sun Y., Allmeroth K., Dieterle S., Sinniger J., Dirrig-Grosch S., et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente Pons A., Higginbottom A., Cooper-Knock J., Alrafiah A., Alofi E., Kirby J., Shaw P.J., Wood J.D., Highley J.R. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. J. Pathol. 2020 doi: 10.1002/path.5455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5455</ArticleId><ArticleId IdType="pubmed">32391572</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida T., Tamaki Y., Ayaki T., Shodai A., Kaji S., Morimura T., Banno Y., Nishitsuji K., Sakashita N., Maki T., et al. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS. Sci. Rep. 2016;6:19118. doi: 10.1038/srep19118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep19118</ArticleId><ArticleId IdType="pmc">PMC4707540</ArticleId><ArticleId IdType="pubmed">26751167</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosin C., Bates T.E., Skaper S.D. Excitatory amino acid induced oligodendrocyte cell death in vitro: Receptor-dependent and -independent mechanisms. J. Neurochem. 2004;90:1173&#x2013;1185. doi: 10.1111/j.1471-4159.2004.02584.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02584.x</ArticleId><ArticleId IdType="pubmed">15312172</ArticleId></ArticleIdList></Reference><Reference><Citation>Vartanian T., Li Y., Zhao M., Stefansson K. Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol. Med. 1995;1:732&#x2013;743. doi: 10.1007/BF03401888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03401888</ArticleId><ArticleId IdType="pmc">PMC2230017</ArticleId><ArticleId IdType="pubmed">8612196</ArticleId></ArticleIdList></Reference><Reference><Citation>Aebischer J., Moumen A., Sazdovitch V., Seilhean D., Meininger V., Raoul C. Elevated levels of IFNgamma and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. Eur. J. Neurol. 2012;19:e745&#x2013;e756. doi: 10.1111/j.1468-1331.2011.03623.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03623.x</ArticleId><ArticleId IdType="pubmed">22221541</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone S., Wu S., Nave K.A., Lin W. The UPR preserves mature oligodendrocyte viability and function in adults by regulating autophagy of PLP. JCI Insight. 2020;5 doi: 10.1172/jci.insight.132364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.132364</ArticleId><ArticleId IdType="pmc">PMC7141389</ArticleId><ArticleId IdType="pubmed">32053121</ArticleId></ArticleIdList></Reference><Reference><Citation>Osseward P.J., 2nd, Pfaff S.L. Cell type and circuit modules in the spinal cord. Curr. Opin. Neurobiol. 2019;56:175&#x2013;184. doi: 10.1016/j.conb.2019.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2019.03.003</ArticleId><ArticleId IdType="pubmed">30954861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Jarquin U.N., Tapia R. Excitatory and Inhibitory Neuronal Circuits in the Spinal Cord and Their Role in the Control of Motor Neuron Function and Degeneration. ACS Chem. Neurosci. 2018;9:211&#x2013;216. doi: 10.1021/acschemneuro.7b00503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.7b00503</ArticleId><ArticleId IdType="pubmed">29350907</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosgnach S. The role of genetically-defined interneurons in generating the mammalian locomotor rhythm. Integr. Comp. Biol. 2011;51:903&#x2013;912. doi: 10.1093/icb/icr022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icb/icr022</ArticleId><ArticleId IdType="pubmed">21576118</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara J.H., Genc B., Klessner J.L., Ozdinler P.H. Retrograde labeling, transduction, and genetic targeting allow cellular analysis of corticospinal motor neurons: Implications in health and disease. Front. Neuroanat. 2014;8:16. doi: 10.3389/fnana.2014.00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2014.00016</ArticleId><ArticleId IdType="pmc">PMC3972458</ArticleId><ArticleId IdType="pubmed">24723858</ArticleId></ArticleIdList></Reference><Reference><Citation>Oswald M.J., Tantirigama M.L., Sonntag I., Hughes S.M., Empson R.M. Diversity of layer 5 projection neurons in the mouse motor cortex. Front. Cell Neurosci. 2013;7:174. doi: 10.3389/fncel.2013.00174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00174</ArticleId><ArticleId IdType="pmc">PMC3797544</ArticleId><ArticleId IdType="pubmed">24137110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaguchi Y. Pyramidal Cell Subtypes and Their Synaptic Connections in Layer 5 of Rat Frontal Cortex. Cereb Cortex. 2017;27:5755&#x2013;5771. doi: 10.1093/cercor/bhx252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhx252</ArticleId><ArticleId IdType="pubmed">29028949</ArticleId></ArticleIdList></Reference><Reference><Citation>Naka A., Adesnik H. Inhibitory Circuits in Cortical Layer 5. Front. Neural. Circuits. 2016;10:35. doi: 10.3389/fncir.2016.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2016.00035</ArticleId><ArticleId IdType="pmc">PMC4859073</ArticleId><ArticleId IdType="pubmed">27199675</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S., Cheah B.C., Yiannikas C., Kiernan M.C. Cortical excitability distinguishes ALS from mimic disorders. Clin. Neurophysiol. 2011;122:1860&#x2013;1866. doi: 10.1016/j.clinph.2010.12.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2010.12.062</ArticleId><ArticleId IdType="pubmed">21382747</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S., Nicholson G.A., Kiernan M.C. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008;131:1540&#x2013;1550. doi: 10.1093/brain/awn071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn071</ArticleId><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanette G., Tamburin S., Manganotti P., Refatti N., Forgione A., Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clin. Neurophysiol. 2002;113:1688&#x2013;1697. doi: 10.1016/S1388-2457(02)00288-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-2457(02)00288-2</ArticleId><ArticleId IdType="pubmed">12417221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanette G., Tamburin S., Manganotti P., Refatti N., Forgione A., Rizzuto N. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis. J. Neurol. 2002;249:1723&#x2013;1728. doi: 10.1007/s00415-002-0926-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-002-0926-7</ArticleId><ArticleId IdType="pubmed">12529797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemann U., Winter M., Reimers C.D., Reimers K., Tergau F., Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology. 1997;49:1292&#x2013;1298. doi: 10.1212/WNL.49.5.1292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.49.5.1292</ArticleId><ArticleId IdType="pubmed">9371911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei K., Kowall N.W. Involvement of NPY-immunoreactive neurons in the cerebral cortex of amyotrophic lateral sclerosis patients. Neurosci. Lett. 1993;159:67&#x2013;70. doi: 10.1016/0304-3940(93)90800-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(93)90800-Z</ArticleId><ArticleId IdType="pubmed">8264981</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens B., Guiloff R.J., Navarrete R., Newman P., Nikhar N., Lewis P. Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study. J. Neurol. Sci. 2006;244:41&#x2013;58. doi: 10.1016/j.jns.2005.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.12.003</ArticleId><ArticleId IdType="pubmed">16487542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince P., Stout N., Shaw P., Slade J., Hunziker W., Heizmann C.W., Baimbridge K.G. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol. Appl. Neurobiol. 1993;19:291&#x2013;299. doi: 10.1111/j.1365-2990.1993.tb00443.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1993.tb00443.x</ArticleId><ArticleId IdType="pubmed">8232749</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa S., Al-Sarraj S., Kibble M., Landau S., Parnavelas J., Cotter D., Everall I., Leigh P.N. Cortical selective vulnerability in motor neuron disease: A morphometric study. Brain. 2004;127:1237&#x2013;1251. doi: 10.1093/brain/awh132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh132</ArticleId><ArticleId IdType="pubmed">15130949</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei K., McKee A.C., Kowall N.W. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol. 1993;86:55&#x2013;64. doi: 10.1007/BF00454899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00454899</ArticleId><ArticleId IdType="pubmed">8396837</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster B.R., Callaghan B.C., Petrou M., Edden R.A., Chenevert T.L., Feldman E.L. Decreased motor cortex gamma-aminobutyric acid in amyotrophic lateral sclerosis. Neurology. 2012;78:1596&#x2013;1600. doi: 10.1212/WNL.0b013e3182563b57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182563b57</ArticleId><ArticleId IdType="pmc">PMC3348851</ArticleId><ArticleId IdType="pubmed">22517106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd C.M., Richardson M.P., Brooks D.J., Al-Chalabi A., Leigh P.N. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain. 2000;123:2289&#x2013;2296. doi: 10.1093/brain/123.11.2289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/123.11.2289</ArticleId><ArticleId IdType="pubmed">11050028</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung Y.H., Joo K.M., Nam R.H., Cho M.H., Kim D.J., Lee W.B., Cha C.I. Decreased expression of calretinin in the cerebral cortex and hippocampus of SOD1G93A transgenic mice. Brain Res. 2005;1035:105&#x2013;109. doi: 10.1016/j.brainres.2004.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.12.022</ArticleId><ArticleId IdType="pubmed">15713283</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark R.M., Blizzard C.A., Young K.M., King A.E., Dickson T.C. Calretinin and Neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1(G93A) mouse model of ALS. Sci. Rep. 2017;7:44461. doi: 10.1038/srep44461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44461</ArticleId><ArticleId IdType="pmc">PMC5353592</ArticleId><ArticleId IdType="pubmed">28294153</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison B.M., Janssen W.G., Gordon J.W., Morrison J.H. Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice. J. Comp. Neurol. 1998;391:64&#x2013;77. doi: 10.1002/(SICI)1096-9861(19980202)391:1&lt;64::AID-CNE6&gt;3.0.CO;2-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(19980202)391:1&lt;64::AID-CNE6&gt;3.0.CO;2-P</ArticleId><ArticleId IdType="pubmed">9527542</ArticleId></ArticleIdList></Reference><Reference><Citation>Niessen H.G., Debska-Vielhaber G., Sander K., Angenstein F., Ludolph A.C., Hilfert L., Willker W., Leibfritz D., Heinze H.J., Kunz W.S., et al. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2007;25:1669&#x2013;1677. doi: 10.1111/j.1460-9568.2007.05415.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2007.05415.x</ArticleId><ArticleId IdType="pubmed">17432958</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Zhang L., Liang B., Schroeder D., Zhang Z.W., Cox G.A., Li Y., Lin D.T. Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders. Nat. Neurosci. 2016;19:557&#x2013;559. doi: 10.1038/nn.4257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4257</ArticleId><ArticleId IdType="pmc">PMC4811704</ArticleId><ArticleId IdType="pubmed">26900927</ArticleId></ArticleIdList></Reference><Reference><Citation>McGown A., McDearmid J.R., Panagiotaki N., Tong H., Al Mashhadi S., Redhead N., Lyon A.N., Beattie C.E., Shaw P.J., Ramesh T.M. Early interneuron dysfunction in ALS: Insights from a mutant sod1 zebrafish model. Ann. Neurol. 2013;73:246&#x2013;258. doi: 10.1002/ana.23780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23780</ArticleId><ArticleId IdType="pmc">PMC3608830</ArticleId><ArticleId IdType="pubmed">23281025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo J.J., Schonewille M., Siddique T., Schults A.N., Fu R., Bar P.R., Anelli R., Heckman C.J., Kroese A.B. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. J. Neurophysiol. 2004;91:571&#x2013;575. doi: 10.1152/jn.00665.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00665.2003</ArticleId><ArticleId IdType="pubmed">14523070</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B., Peuscher M.H., Hynynen M., Chen A., Neve R.L., Brown R.H., Jr., Constantine-Paton M., Bellingham M.C. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J. Neurosci. 2008;28:10864&#x2013;10874. doi: 10.1523/JNEUROSCI.1340-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1340-08.2008</ArticleId><ArticleId IdType="pmc">PMC3844745</ArticleId><ArticleId IdType="pubmed">18945894</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Zappettini S., Jacchetti E., Bonifacino T., Cervetto C., Usai C., Bonanno G. In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2010;113:489&#x2013;501. doi: 10.1111/j.1471-4159.2010.06628.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06628.x</ArticleId><ArticleId IdType="pubmed">20132478</ArticleId></ArticleIdList></Reference><Reference><Citation>Carunchio I., Mollinari C., Pieri M., Merlo D., Zona C. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2008;28:1275&#x2013;1285. doi: 10.1111/j.1460-9568.2008.06436.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2008.06436.x</ArticleId><ArticleId IdType="pubmed">18973555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Gonzalez J.L., Moser J., Lauritzen M., Schmitt-John T., Jensen K. Reduced GABAergic inhibition explains cortical hyperexcitability in the wobbler mouse model of ALS. Cereb Cortex. 2011;21:625&#x2013;635. doi: 10.1093/cercor/bhq134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhq134</ArticleId><ArticleId IdType="pubmed">20643756</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser J.M., Bigini P., Schmitt-John T. The wobbler mouse, an ALS animal model. Mol. Genet. Genom. 2013;288:207&#x2013;229. doi: 10.1007/s00438-013-0741-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00438-013-0741-0</ArticleId><ArticleId IdType="pmc">PMC3664746</ArticleId><ArticleId IdType="pubmed">23539154</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Q., Martin L.J. Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: A quantitative confocal analysis. Am. J. Pathol. 2009;174:574&#x2013;585. doi: 10.2353/ajpath.2009.080557.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.080557</ArticleId><ArticleId IdType="pmc">PMC2630565</ArticleId><ArticleId IdType="pubmed">19116365</ArticleId></ArticleIdList></Reference><Reference><Citation>Wootz H., Fitzsimons-Kantamneni E., Larhammar M., Rotterman T.M., Enjin A., Patra K., Andre E., Van Zundert B., Kullander K., Alvarez F.J. Alterations in the motor neuron-renshaw cell circuit in the Sod1(G93A) mouse model. J. Comp. Neurol. 2013;521:1449&#x2013;1469. doi: 10.1002/cne.23266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23266</ArticleId><ArticleId IdType="pmc">PMC3604165</ArticleId><ArticleId IdType="pubmed">23172249</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas C., Herrando-Grabulosa M., Manzano R., Mancuso R., Osta R., Navarro X. Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav. 2013;3:145&#x2013;158. doi: 10.1002/brb3.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.104</ArticleId><ArticleId IdType="pmc">PMC3607155</ArticleId><ArticleId IdType="pubmed">23531559</ArticleId></ArticleIdList></Reference><Reference><Citation>Raynor E.M., Shefner J.M. Recurrent inhibition is decreased in patients with amyotrophic lateral sclerosis. Neurology. 1994;44:2148&#x2013;2153. doi: 10.1212/WNL.44.11.2148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.44.11.2148</ArticleId><ArticleId IdType="pubmed">7969975</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K., Huang H., Peterson A., Hu B., Maragakis N.J., Ming G.L., Chen H., Zhang S.C. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem. Cell Rep. 2017;8:843&#x2013;855. doi: 10.1016/j.stemcr.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick N.D., Griffey C.J., Guarnieri P., Gerbino V., Wang X., Piersaint J.A., Tapia J.C., Rich M.M., Maniatis T. Distinct roles for motor neuron autophagy early and late in the SOD1(G93A) mouse model of ALS. Proc. Natl. Acad. Sci. USA. 2017;114:E8294&#x2013;E8303. doi: 10.1073/pnas.1704294114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704294114</ArticleId><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Enjin A., Rabe N., Nakanishi S.T., Vallstedt A., Gezelius H., Memic F., Lind M., Hjalt T., Tourtellotte W.G., Bruder C., et al. Identification of novel spinal cholinergic genetic subtypes disclose Chodl and Pitx2 as markers for fast motor neurons and partition cells. J. Comp. Neurol. 2010;518:2284&#x2013;2304. doi: 10.1002/cne.22332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.22332</ArticleId><ArticleId IdType="pubmed">20437528</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagoraiou L., Akay T., Martin J.F., Brownstone R.M., Jessell T.M., Miles G.B. A cluster of cholinergic premotor interneurons modulates mouse locomotor activity. Neuron. 2009;64:645&#x2013;662. doi: 10.1016/j.neuron.2009.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.10.017</ArticleId><ArticleId IdType="pmc">PMC2891428</ArticleId><ArticleId IdType="pubmed">20005822</ArticleId></ArticleIdList></Reference><Reference><Citation>Witts E.C., Zagoraiou L., Miles G.B. Anatomy and function of cholinergic C bouton inputs to motor neurons. J. Anat. 2014;224:52&#x2013;60. doi: 10.1111/joa.12063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.12063</ArticleId><ArticleId IdType="pmc">PMC3867887</ArticleId><ArticleId IdType="pubmed">23701140</ArticleId></ArticleIdList></Reference><Reference><Citation>Deardorff A.S., Romer S.H., Sonner P.M., Fyffe R.E. Swimming against the tide: Investigations of the C-bouton synapse. Front. Neural. Circuits. 2014;8:106. doi: 10.3389/fncir.2014.00106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2014.00106</ArticleId><ArticleId IdType="pmc">PMC4167003</ArticleId><ArticleId IdType="pubmed">25278842</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampieri N., Jessell T.M., Murray A.J. Mapping sensory circuits by anterograde transsynaptic transfer of recombinant rabies virus. Neuron. 2014;81:766&#x2013;778. doi: 10.1016/j.neuron.2013.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.033</ArticleId><ArticleId IdType="pmc">PMC3988472</ArticleId><ArticleId IdType="pubmed">24486087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Lanuza G.M., Britz O., Wang Z., Siembab V.C., Zhang Y., Velasquez T., Alvarez F.J., Frank E., Goulding M. V1 and v2b interneurons secure the alternating flexor-extensor motor activity mice require for limbed locomotion. Neuron. 2014;82:138&#x2013;150. doi: 10.1016/j.neuron.2014.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.02.013</ArticleId><ArticleId IdType="pmc">PMC4096991</ArticleId><ArticleId IdType="pubmed">24698273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellstrom J., Oliveira A.L., Meister B., Cullheim S. Large cholinergic nerve terminals on subsets of motoneurons and their relation to muscarinic receptor type 2. J. Comp. Neurol. 2003;460:476&#x2013;486. doi: 10.1002/cne.10648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.10648</ArticleId><ArticleId IdType="pubmed">12717708</ArticleId></ArticleIdList></Reference><Reference><Citation>Soulard C., Salsac C., Mouzat K., Hilaire C., Roussel J., Mezghrani A., Lumbroso S., Raoul C., Scamps F. Spinal Motoneuron TMEM16F Acts at C-boutons to Modulate Motor Resistance and Contributes to ALS Pathogenesis. Cell Rep. 2020;30:2581&#x2013;2593 e2587. doi: 10.1016/j.celrep.2020.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.001</ArticleId><ArticleId IdType="pubmed">32101737</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao M., Misawa H., Kato S., Hirai S. Loss of cholinergic synapses on the spinal motor neurons of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1998;57:329&#x2013;333. doi: 10.1097/00005072-199804000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199804000-00004</ArticleId><ArticleId IdType="pubmed">9600225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasiene J., Komine O., Fujimori-Tonou N., Powers B., Endo F., Watanabe S., Shijie J., Ravits J., Horner P., Misawa H., et al. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons. Acta Neuropathol. Commun. 2016;4:15. doi: 10.1186/s40478-016-0286-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0286-7</ArticleId><ArticleId IdType="pmc">PMC4758105</ArticleId><ArticleId IdType="pubmed">26891847</ArticleId></ArticleIdList></Reference><Reference><Citation>Milan L., Courtand G., Cardoit L., Masmejean F., Barriere G., Cazalets J.R., Garret M., Bertrand S.S. Age-Related Changes in Pre- and Postsynaptic Partners of the Cholinergic C-Boutons in Wild-Type and SOD1G93A Lumbar Motoneurons. PLoS ONE. 2015;10:e0135525. doi: 10.1371/journal.pone.0135525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135525</ArticleId><ArticleId IdType="pmc">PMC4549056</ArticleId><ArticleId IdType="pubmed">26305672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen A.H., Athanasiou D. Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. Eur. J. Neurosci. 2009;29:551&#x2013;561. doi: 10.1111/j.1460-9568.2008.06602.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2008.06602.x</ArticleId><ArticleId IdType="pubmed">19187267</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Roselli F., Singh K., Leptien K., Julien J.P., Gros-Louis F., Caroni P. Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival. Neuron. 2013;80:80&#x2013;96. doi: 10.1016/j.neuron.2013.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.027</ArticleId><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>Herron L.R., Miles G.B. Gender-specific perturbations in modulatory inputs to motoneurons in a mouse model of amyotrophic lateral sclerosis. Neuroscience. 2012;226:313&#x2013;323. doi: 10.1016/j.neuroscience.2012.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.09.031</ArticleId><ArticleId IdType="pubmed">23000617</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukkipati S.S., Chihi A., Wang Y., Elbasiouny S.M. Experimental Design and Data Analysis Issues Contribute to Inconsistent Results of C-Bouton Changes in Amyotrophic Lateral Sclerosis. eNeuro. 2017;4 doi: 10.1523/ENEURO.0281-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0281-16.2016</ArticleId><ArticleId IdType="pmc">PMC5241941</ArticleId><ArticleId IdType="pubmed">28101533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallart-Palau X., Tarabal O., Casanovas A., Sabado J., Correa F.J., Hereu M., Piedrafita L., Caldero J., Esquerda J.E. Neuregulin-1 is concentrated in the postsynaptic subsurface cistern of C-bouton inputs to alpha-motoneurons and altered during motoneuron diseases. FASEB J. 2014;28:3618&#x2013;3632. doi: 10.1096/fj.13-248583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.13-248583</ArticleId><ArticleId IdType="pubmed">24803543</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni L.M., Myles J.R., Wells T.L., Mayer W.P., Akay T. Cholinergic modulation of motor neurons through the C-boutons are necessary for the locomotor compensation for severe motor neuron loss during amyotrophic lateral sclerosis disease progression. Behav. Brain Res. 2019;369:111914. doi: 10.1016/j.bbr.2019.111914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2019.111914</ArticleId><ArticleId IdType="pubmed">31022419</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvany S., Casanovas A., Tarabal O., Piedrafita L., Hernandez S., Santafe M., Soto-Bernardini M.C., Caldero J., Schwab M.H., Esquerda J.E. Localization and dynamic changes of neuregulin-1 at C-type synaptic boutons in association with motor neuron injury and repair. FASEB J. 2019;33:7833&#x2013;7851. doi: 10.1096/fj.201802329R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802329R</ArticleId><ArticleId IdType="pubmed">30912977</ArticleId></ArticleIdList></Reference><Reference><Citation>Dentel C., Palamiuc L., Henriques A., Lannes B., Spreux-Varoquaux O., Gutknecht L., Rene F., Echaniz-Laguna A., Gonzalez de Aguilar J.L., Lesch K.P., et al. Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: A link to spasticity. Brain. 2013;136:483&#x2013;493. doi: 10.1093/brain/aws274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws274</ArticleId><ArticleId IdType="pubmed">23114367</ArticleId></ArticleIdList></Reference><Reference><Citation>El Oussini H., Scekic-Zahirovic J., Vercruysse P., Marques C., Dirrig-Grosch S., Dieterle S., Picchiarelli G., Sinniger J., Rouaux C., Dupuis L. Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis. Ann. Neurol. 2017;82:444&#x2013;456. doi: 10.1002/ana.25030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25030</ArticleId><ArticleId IdType="pubmed">28856708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., Oda M., Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 1993;19:300&#x2013;304. doi: 10.1111/j.1365-2990.1993.tb00444.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1993.tb00444.x</ArticleId><ArticleId IdType="pubmed">7901781</ArticleId></ArticleIdList></Reference><Reference><Citation>Borasio G.D., Linke R., Schwarz J., Schlamp V., Abel A., Mozley P.D., Tatsch K. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography. J. Neurol. Neurosurg. Psychiatry. 1998;65:263&#x2013;265. doi: 10.1136/jnnp.65.2.263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.65.2.263</ArticleId><ArticleId IdType="pmc">PMC2170216</ArticleId><ArticleId IdType="pubmed">9703186</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H., Snow B.J., Bhatt M.H., Peppard R., Eisen A., Calne D.B. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet. 1993;342:1016&#x2013;1018. doi: 10.1016/0140-6736(93)92878-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)92878-W</ArticleId><ArticleId IdType="pubmed">8105264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostic V., Gurney M.E., Deng H.X., Siddique T., Epstein C.J., Przedborski S. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 1997;41:497&#x2013;504. doi: 10.1002/ana.410410413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410410413</ArticleId><ArticleId IdType="pubmed">9124807</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J., Paz-Fajardo L., Lopez de Munain A. Clinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosis. Br. J. Pharm. 2020 doi: 10.1111/bph.15202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15202</ArticleId><ArticleId IdType="pubmed">32673410</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Q.Q., Wei Q., Wu Z.Y. Sensory nerve disturbance in amyotrophic lateral sclerosis. Life Sci. 2018;203:242&#x2013;245. doi: 10.1016/j.lfs.2018.04.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2018.04.052</ArticleId><ArticleId IdType="pubmed">29709651</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki S., Yamamoto T., Quinn K., Spigelman I., Pantazis A., Olcese R., Wiedau-Pazos M., Chandler S.H., Venugopal S. Circuit-Specific Early Impairment of Proprioceptive Sensory Neurons in the SOD1(G93A) Mouse Model for ALS. J. Neurosci. 2019;39:8798&#x2013;8815. doi: 10.1523/JNEUROSCI.1214-19.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1214-19.2019</ArticleId><ArticleId IdType="pmc">PMC6820216</ArticleId><ArticleId IdType="pubmed">31530644</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto M.C., Gurney M.E. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS) Brain Res. 1995;676:25&#x2013;40. doi: 10.1016/0006-8993(95)00063-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(95)00063-V</ArticleId><ArticleId IdType="pubmed">7796176</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan S.K., Kemp Z., Hatzipetros T., Vieira F., Valdez G. Degeneration of proprioceptive sensory nerve endings in mice harboring amyotrophic lateral sclerosis-causing mutations. J. Comp. Neurol. 2015;523:2477&#x2013;2494. doi: 10.1002/cne.23848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23848</ArticleId><ArticleId IdType="pmc">PMC5759336</ArticleId><ArticleId IdType="pubmed">26136049</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendrick S.E., Xue Q.S., Streit W.J. Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene. J. Neuroinflammation. 2007;4:9. doi: 10.1186/1742-2094-4-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-4-9</ArticleId><ArticleId IdType="pmc">PMC1808448</ArticleId><ArticleId IdType="pubmed">17328801</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit W.J., Xue Q.S. Life and death of microglia. J. Neuroimmune Pharm. 2009;4:371&#x2013;379. doi: 10.1007/s11481-009-9163-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9163-5</ArticleId><ArticleId IdType="pubmed">19680817</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>